LT3344B - Cetirizine-containing antialergic solution for opthalmic or nasal use - Google Patents

Cetirizine-containing antialergic solution for opthalmic or nasal use Download PDF

Info

Publication number
LT3344B
LT3344B LTIP1669A LTIP1669A LT3344B LT 3344 B LT3344 B LT 3344B LT IP1669 A LTIP1669 A LT IP1669A LT IP1669 A LTIP1669 A LT IP1669A LT 3344 B LT3344 B LT 3344B
Authority
LT
Lithuania
Prior art keywords
cetirizine
cyclodextrin
solution
allergic
allergic composition
Prior art date
Application number
LTIP1669A
Other languages
English (en)
Lithuanian (lt)
Inventor
Yohifumi Ikejiri
Takahiro Ogawa
Fuminori Tokumochi
Shogo Sameshima
Motoko Kimura
Original Assignee
Senju Pharma Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senju Pharma Co filed Critical Senju Pharma Co
Publication of LTIP1669A publication Critical patent/LTIP1669A/xx
Publication of LT3344B publication Critical patent/LT3344B/lt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/724—Cyclodextrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/81—Drug, bio-affecting and body treating compositions involving autoimmunity, allergy, immediate hypersensitivity, delayed hypersensitivity, immunosuppression, immunotolerance, or anergy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
LTIP1669A 1992-12-25 1993-12-23 Cetirizine-containing antialergic solution for opthalmic or nasal use LT3344B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP34603192 1992-12-25

Publications (2)

Publication Number Publication Date
LTIP1669A LTIP1669A (en) 1994-10-25
LT3344B true LT3344B (en) 1995-07-25

Family

ID=18380671

Family Applications (1)

Application Number Title Priority Date Filing Date
LTIP1669A LT3344B (en) 1992-12-25 1993-12-23 Cetirizine-containing antialergic solution for opthalmic or nasal use

Country Status (23)

Country Link
US (1) US5419898A (no)
EP (1) EP0605203B1 (no)
JP (1) JP3683595B2 (no)
KR (1) KR100276743B1 (no)
CN (1) CN1050514C (no)
AT (1) ATE164068T1 (no)
AU (1) AU666413B2 (no)
BG (1) BG61101B1 (no)
CA (1) CA2112014C (no)
CZ (1) CZ283029B6 (no)
DE (1) DE69317537T2 (no)
DK (1) DK0605203T3 (no)
ES (1) ES2115733T3 (no)
FI (1) FI111805B (no)
HU (2) HU218672B (no)
LT (1) LT3344B (no)
LV (1) LV10688B (no)
NO (2) NO934630D0 (no)
NZ (1) NZ250519A (no)
PL (1) PL173347B1 (no)
RU (1) RU2130774C1 (no)
SK (1) SK279503B6 (no)
TW (1) TW401300B (no)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5897858A (en) 1994-02-03 1999-04-27 Schering-Plough Healthcare Products, Inc. Nasal spray compositions exhibiting increased retention in the nasal cavity
EP0780127A1 (en) * 1995-12-19 1997-06-25 The Procter & Gamble Company A nasal spray containing a steroid and a antihistamine
US5976573A (en) * 1996-07-03 1999-11-02 Rorer Pharmaceutical Products Inc. Aqueous-based pharmaceutical composition
WO1998013001A1 (en) * 1996-09-27 1998-04-02 Nastech Pharmaceutical Company, Inc. Intranasal formulations for promoting sleep and method of using the same
BE1011251A3 (fr) * 1997-07-03 1999-06-01 Ucb Sa Compositions pharmaceutiques administrables par voie orale, comprenant une substance active et une cyclodextrine.
EP0919550A1 (en) * 1997-11-26 1999-06-02 Ucb, S.A. Pseudopolymorphic forms of 2-2-4-bis(4-fluorophenyl)methyl-1-piperazinyl-ethoxy acetic acid dihydrochloride
DE19814256A1 (de) * 1998-03-31 1999-10-07 Asta Medica Ag Feste, schnellzerfallende Cetirizin-Formulierungen
IT1303671B1 (it) * 1998-07-28 2001-02-23 Nicox Sa Sali dell'acido nitrico con farmaci attivi nel trattamento dipatologie del sistema respiratorio
US20030059440A1 (en) * 1998-09-01 2003-03-27 Tim Clarot Composition and method for moisturizing nasal tissue
JP2002523475A (ja) 1998-09-02 2002-07-30 アラーガン・セイルズ・インコーポレイテッド 防腐したシクロデキストリン含有組成物
BR9804993A (pt) * 1998-11-10 2000-06-06 Panacea Biotec Ltd Composição antialérgica e antiinflamatória
JP2001125052A (ja) * 1999-10-25 2001-05-11 Lion Corp コンタクトレンズ装着液
US6258814B1 (en) * 2000-10-13 2001-07-10 Schering Corporation Method of using cetirizine and pharmaceutical compositions containing the same for inducing sleep
AU2003201161B2 (en) * 2002-01-15 2008-02-28 Ucb Farchim S.A. Formulations
JP4543274B2 (ja) * 2002-10-01 2010-09-15 大正製薬株式会社 点鼻剤組成物
US6933289B2 (en) 2003-07-01 2005-08-23 Allergan, Inc. Inhibition of irritating side effects associated with use of a topical ophthalmic medication
US20070020299A1 (en) * 2003-12-31 2007-01-25 Pipkin James D Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid
US20050255154A1 (en) 2004-05-11 2005-11-17 Lena Pereswetoff-Morath Method and composition for treating rhinitis
US8216610B2 (en) * 2004-05-28 2012-07-10 Imaginot Pty Ltd. Oral paracetamol formulations
WO2005115345A1 (en) * 2004-05-28 2005-12-08 Imaginot Pty Ltd Oral therapeutic compound delivery system
JP2006008568A (ja) * 2004-06-24 2006-01-12 Cyclochem:Kk ＩｇＥ抗体抑制剤および食品
PE20060484A1 (es) * 2004-07-14 2006-07-06 Ucb Farchim Sa Preparaciones farmaceuticas liquidas que comprenden un compuesto de benzhidril piperizina
WO2006011051A1 (en) * 2004-07-22 2006-02-02 Pfizer Products Inc. Taste masking formulation comprising the drug in a dissolution-retarded form and/or cyclodextrin in a dissolution-enhanced form
EP2336117A1 (en) 2005-05-26 2011-06-22 Neuron Systems, Inc Heterocyclic compounds for treating retinal diseases
JPWO2006137433A1 (ja) * 2005-06-21 2009-01-22 わかもと製薬株式会社 レボカバスチンを可溶化させた水性薬剤
CA2629904C (en) * 2005-11-28 2018-07-10 Imaginot Pty Ltd. Oral therapeutic compound delivery system
KR101382922B1 (ko) * 2006-03-13 2014-04-08 가부시키가이샤 아루떼꾸 우에노 수성 조성물
WO2008025560A1 (en) * 2006-09-01 2008-03-06 Pari Pharma Gmbh Methods for taste masking of nebulised compositions for nasal and pulmonary inhalation therapy
CN101284026B (zh) * 2007-04-12 2010-11-10 鲁南制药集团股份有限公司 一种用于治疗皮肤过敏性疾病的药物组合物
US9358242B2 (en) * 2007-08-30 2016-06-07 Prelief Inc. Calcium glycerophosphate for treating and preventing respiratory diseases or conditions
ES2910374T3 (es) 2009-03-17 2022-05-12 Nicox Ophthalmics Inc Formulaciones oftálmicas de cetirizina y procedimientos de uso
US8569273B2 (en) * 2009-03-17 2013-10-29 Aciex Therapeutics, Inc. Ophthalmic formulations of cetirizine and methods of use
US8513259B2 (en) 2009-07-03 2013-08-20 Jdp Therapeutics, Inc. Non-sedating antihistamine injection formulations and methods of use thereof
US8263581B2 (en) * 2009-07-03 2012-09-11 Jdp Therapeutics, Inc. Non-sedating antihistamine injection formulations and methods of use thereof
WO2011017909A1 (zh) * 2009-08-12 2011-02-17 鲁南贝特制药有限公司 盐酸西替利嗪的药物溶液
CA2780151A1 (en) 2009-11-06 2011-05-12 Yale University Amphiphilic comp0unds and methods for preparing and using same
EP3446692A1 (en) 2011-11-29 2019-02-27 Jurox Pty. Ltd. Methods of preserving injectable pharmaceutical compositions comprising a cyclodextrin and a hydrophobic drug
KR102243169B1 (ko) 2013-01-23 2021-04-22 알데이라 테라퓨틱스, 아이엔씨. 독성 알데히드 관련된 질병 및 치료
CA2996183A1 (en) 2015-08-21 2017-03-02 Aldeyra Therapeutics, Inc. Deuterated compounds and uses thereof
WO2017147617A1 (en) 2016-02-28 2017-08-31 Aldeyra Therapeutics, Inc. Treatment of allergic eye conditions with cyclodextrins
EP3454858A4 (en) 2016-05-09 2020-01-15 Aldeyra Therapeutics, Inc. POLYTHERAPY OF DISORDERS AND INFLAMMATORY EYE DISEASES
JP6843896B2 (ja) * 2017-02-13 2021-03-17 日東メディック株式会社 水性点眼点鼻用組成物
ES2968462T3 (es) 2017-03-16 2024-05-09 Aldeyra Therapeutics Inc Sal polimórfica de 6-cloro-3-amino-2(2-hidroxiprolil) quinolina y usos de la misma
MX2020003425A (es) 2017-10-10 2020-07-29 Aldeyra Therapeutics Inc Tratamiento de trastornos inflamatorios.
LT3740191T (lt) 2018-01-18 2021-08-10 Faes Farma, S.A. Oftalmologinės kompozicijos, apimančios bilastiną, beta-ciklodekstriną ir bent vieną gelinimo agentą
WO2020033344A1 (en) 2018-08-06 2020-02-13 Aldeyra Therapeutics, Inc. Polymorphic compounds and uses thereof
CN115869258A (zh) 2018-09-25 2023-03-31 奥尔德拉医疗公司 用于治疗干眼病的调配物
JP2022526917A (ja) 2019-03-26 2022-05-27 アルデイラ セラピューティクス， インコーポレイテッド 眼科用製剤およびその使用

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06311353A (ja) 1993-04-19 1994-11-04 Brother Ind Ltd カラー画像形成装置
JPH09339A (ja) 1996-06-17 1997-01-07 Kyushu Hitachi Maxell Ltd 電動式爪みがき機

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI75816C (fi) * 1981-02-06 1988-08-08 Ucb Sa Foerfarande foer framstaellning av terapeutiskt aktiv 2-/4-(difenylmetyl)-1-piperazinyl/-aettiksyror eller dess amid.
NZ224497A (en) * 1987-05-18 1990-04-26 Janssen Pharmaceutica Nv Pharmaceutical composition comprising flunarizine
US5188826A (en) * 1988-02-08 1993-02-23 Insite Vision Incorporated Topical ophthalmic suspensions
US5192780A (en) * 1989-12-18 1993-03-09 Alcon Laboratories, Inc. Methods using antiallergics and antihistamines
AU636685B2 (en) * 1989-12-18 1993-05-06 Alcon Laboratories, Inc. Compositions of antiallergics and antihistamines and methods for their use
IT1246188B (it) * 1990-07-27 1994-11-16 Resa Farma Procedimento per la preparazione di composizioni farmaceutiche aventi aumentata velocita' di dissoluzione della sostanza attiva e composizioni ottenute.

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06311353A (ja) 1993-04-19 1994-11-04 Brother Ind Ltd カラー画像形成装置
JPH09339A (ja) 1996-06-17 1997-01-07 Kyushu Hitachi Maxell Ltd 電動式爪みがき機

Also Published As

Publication number Publication date
KR100276743B1 (ko) 2001-01-15
TW401300B (en) 2000-08-11
EP0605203A2 (en) 1994-07-06
CA2112014A1 (en) 1994-06-26
HUT69385A (en) 1995-09-28
US5419898A (en) 1995-05-30
JP3683595B2 (ja) 2005-08-17
PL173347B1 (pl) 1998-02-27
DE69317537T2 (de) 1998-07-09
CZ283029B6 (cs) 1997-12-17
PL301588A1 (en) 1994-06-27
LTIP1669A (en) 1994-10-25
EP0605203B1 (en) 1998-03-18
HU218672B (hu) 2000-10-28
BG98327A (bg) 1994-08-30
LV10688A (lv) 1995-06-20
CN1050514C (zh) 2000-03-22
BG61101B1 (bg) 1996-11-29
ES2115733T3 (es) 1998-07-01
SK279503B6 (sk) 1998-12-02
AU5259793A (en) 1994-07-07
CZ283693A3 (en) 1994-07-13
FI935851A0 (fi) 1993-12-23
HU211972A9 (en) 1996-01-29
CA2112014C (en) 2004-11-02
DE69317537D1 (de) 1998-04-23
LV10688B (en) 1995-10-20
SK147493A3 (en) 1994-07-06
NZ250519A (en) 1995-03-28
JPH06239748A (ja) 1994-08-30
HU9303746D0 (en) 1994-04-28
DK0605203T3 (da) 1998-12-07
CN1094614A (zh) 1994-11-09
NO304176B1 (no) 1998-11-09
AU666413B2 (en) 1996-02-08
FI935851A (fi) 1994-06-26
ATE164068T1 (de) 1998-04-15
RU2130774C1 (ru) 1999-05-27
EP0605203A3 (en) 1994-11-02
FI111805B (fi) 2003-09-30
NO934630D0 (no) 1993-12-15
KR940013511A (ko) 1994-07-15
NO934630L (no) 1994-06-27

Similar Documents

Publication Publication Date Title
LT3344B (en) Cetirizine-containing antialergic solution for opthalmic or nasal use
KR100889170B1 (ko) 안구 건조의 치료에 있어서 리멕솔론의 용도
JP2769253B2 (ja) 水性液剤
BR112019009202A2 (pt) Composição para a prevenção ou o tratamento de danos visuais compreendendo ácido ursodeoxicólico
US6476039B1 (en) Ophthalmic composition
EP0807434B1 (en) Anti-inflammatory eyedrops
JPH0228112A (ja) 点眼用眼圧調整剤
WO2002040028A1 (fr) Gouttes pour les yeux en gel antibacterien
NZ264616A (en) Compositions for treating myopia containing a 7-alkyl-5-oxo-benzopyrano[2,3-b]pyridine derivative
TW304879B (no)
WO2022156372A1 (zh) 一种滴眼给药防治干性黄斑病变和视网膜光损伤的眼用制剂
JPH02262518A (ja) 眼圧調整剤
Xiao et al. Thermoreversible In Situ Gel for Ophthalmic Delivery of Ciprofloxacin and Betamethasone for the Treatment of Ocular Degenerative Disease: Assesment in Rabbit
KR100261585B1 (ko) 항염증점안제
KR20230021613A (ko) 안구건조증 치료를 위한 레코플라본 함유 점안 조성물 및 이의 제조방법
WO2023048174A1 (ja) 角膜疾患治療剤
Stefánsson et al. 2-Hydroxypropyl-ß-Cyclodextrin in Eye Drops. Evaluation of Artificial Tear-Drops In Human Patients

Legal Events

Date Code Title Description
MM9A Lapsed patents

Effective date: 20091223